Diazyme's Lp(a) is a dual liquid stable reagent system which provides reliable results and is offered with time saving instrument specific packaging options
which eliminate reagent transfer and increase operator efficiency. Instrument specific packaging options including RocheTM Hitachi 917 series, Beckman AU
(400/600/640/680), Beckman Synchron CX, LX and DXC. The method requires only 6 μl of serum sample completed in less than 10 minutes and has excellent
correlation with existing commercial products with r2 of 0.998, slope of 0.99, and y intercept of 0.03. The assay has intra precision values of less than 2.6%.
Diazyme's Lp(a) Assay is based on a latex enhanced immunoturbidimetric method. Lp(a) in the
sample binds to the specific anti-Lp(a) antibody, which is coated on latex particles, and causes
agglutination. The degree of the turbidity caused by agglutination can be measured optically
and is proportional to the amount of Lp(a) in the sample.
The Diazyme Lp(a) is intended as a latex particle enhanced immunoturbidimetric assay for the in vitro quantitative determination of lipoprotein(a) [Lp(a)]
concentration in human serum or plasma (EDTA) on clinical chemistry systems. The measurement of Lp(a) is useful in evaluating lipid metabolism disorders
and assessing atherosclerotic cardiovascular diseases in specific populations, when used in conjunction with clinical evaluation. For in vitro diagnostic use only.
|Kit (300 Tests)
|| R1: 1 x 60 mL
R2: 1 x 20 mL
|| 5 x 1 mL
|| 2 x 1 mL
|| 3 x 3 mL
||5 x 1 mL
||2 x 1 mL